Phase 4 Multiple Myeloma Clinical Trials
9 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–9 of 9 trials
Recruiting
Phase 4
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Multiple Myeloma
Janssen Research & Development, LLC295 enrolled50 locationsNCT05201781
Recruiting
Phase 4
A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma
Multiple Myeloma
Johnson & Johnson Private Limited75 enrolled12 locationsNCT07030517
Recruiting
Phase 4
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Multiple Myeloma
Emory University94 enrolled1 locationNCT07101445
Recruiting
Phase 4
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Multiple Myeloma
Pfizer80 enrolled25 locationsNCT06057402
Recruiting
Phase 4
Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager
Multiple Myeloma, RefractoryRelapsed Multiple Myeloma
CHU de Quebec-Universite Laval80 enrolled1 locationNCT07094048
Recruiting
Phase 4
Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma
Multiple Myeloma
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT05722405
Recruiting
Phase 4
Plan Development for Giving Teclistamab in the Outpatient Setting
Multiple MyelomaRefractory CancerRelapsed Cancer
University Health Network, Toronto15 enrolled1 locationNCT06251076
Recruiting
Phase 4
Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)
Peripheral NeuropathyMultiple Myeloma, Neoplasms
Tanta University44 enrolled2 locationsNCT07025005
Recruiting
Phase 4
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection
MRDMultiple MyelomaHigh-Risk+1 more
The First Affiliated Hospital of Soochow University59 enrolled1 locationNCT06409702